These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 29464446)

  • 21. Endoscopic imaging in the management of gastroenteropancreatic neuroendocrine tumors.
    Pellicano R; Fagoonee S; Altruda F; Bruno M; Saracco GM; De Angelis C
    Minerva Endocrinol; 2016 Dec; 41(4):490-8. PubMed ID: 27600643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on gastroenteropancreatic neuroendocrine tumors.
    Cives M; Strosberg J
    Oncology (Williston Park); 2014 Sep; 28(9):749-56, 758. PubMed ID: 25224471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pancreatic neuroendocrine tumors].
    Burgos L; Burgos ME
    Rev Med Chil; 2004 May; 132(5):627-34. PubMed ID: 15279151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Will clinical heterogeneity of neuroendocrine tumors impact their management in the future? Lessons from recent trials.
    Cives M; Soares HP; Strosberg J
    Curr Opin Oncol; 2016 Jul; 28(4):359-66. PubMed ID: 27138571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine pancreatic carcinoma.
    Rothmund M; Stinner B; Arnold R
    Eur J Surg Oncol; 1991 Apr; 17(2):191-9. PubMed ID: 1849844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastroenteropancreatic Neuroendocrine Tumors.
    Fernandes CJ; Leung G; Eads JR; Katona BW
    Gastroenterol Clin North Am; 2022 Sep; 51(3):625-647. PubMed ID: 36153114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life in patients with gastroenteropancreatic tumours: A systematic literature review.
    Watson C; Tallentire CW; Ramage JK; Srirajaskanthan R; Leeuwenkamp OR; Fountain D
    World J Gastroenterol; 2020 Jul; 26(25):3686-3711. PubMed ID: 32742136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Alexandraki KI; Karapanagioti A; Karoumpalis I; Boutzios G; Kaltsas GA
    Biomed Res Int; 2017; 2017():9856140. PubMed ID: 29349087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis of and therapy for endocrine tumors of the pancreas].
    Komoto I; Shimada Y; Fujimoto K; Itami A; Kawamura J; Doi R; Imamura M
    Nihon Naika Gakkai Zasshi; 2004 Jan; 93(1):77-83. PubMed ID: 14968578
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of unresectable malignant endocrine tumors of the pancreas.
    Modlin IM; Lewis JJ; Ahlman H; Bilchik AJ; Kumar RR
    Surg Gynecol Obstet; 1993 May; 176(5):507-18. PubMed ID: 8386860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-of-illness of metastatic gastroenteropancreatic neuroendocrine tumours in Sweden-A population-based register-linkage study.
    Lesén E; Granfeldt D; Houchard A; Berthon A; Dinet J; Gabriel S; Björstad Å; Björholt I; Elf AK; Johanson V
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12983. PubMed ID: 30652364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Diarrhea in Patients With Carcinoid Syndrome.
    Naraev BG; Halland M; Halperin DM; Purvis AJ; OʼDorisio TM; Halfdanarson TR
    Pancreas; 2019 Sep; 48(8):961-972. PubMed ID: 31425482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gastroenteropancreatic neuroendocrine neoplasms-Heterogeneity, management and perspectives of treatment and research].
    Luley K; Gebauer J; Gebauer N; Tharun L; Buchmann I; Barkhausen J; von Bubnoff N; Lindner K; Keck T; Lehnert H; Schmid SM
    Internist (Berl); 2020 Aug; 61(8):875-890. PubMed ID: 32676723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment.
    Ro C; Chai W; Yu VE; Yu R
    Chin J Cancer; 2013 Jun; 32(6):312-24. PubMed ID: 23237225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroendocrine tumors of the pancreas.
    Dadan J; Wojskowicz P; Wojskowicz A
    Wiad Lek; 2008; 61(1-3):43-7. PubMed ID: 18717042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuroendocrine well-differentiated pancreatic tumors].
    Niccoli P
    Rev Prat; 2015 Apr; 65(4):461-5. PubMed ID: 26058180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuroendocrine tumors of the pancreas and gastrointestinal tract].
    Höring E; von Gaisberg U
    Dtsch Med Wochenschr; 1991 Aug; 116(31-32):1197-202. PubMed ID: 1677619
    [No Abstract]   [Full Text] [Related]  

  • 38. Hegemony and cost-effectiveness of endoscopic ultrasound (EUS) in the field of gastroenteropancreatic-neuroendocrine tumors (GEP-NETs).
    De Angelis C; Manfrè SF; Bruno M; Pellicano R
    Minerva Med; 2014 Oct; 105(5):363-70. PubMed ID: 25325565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
    Kanakis G; Kaltsas G
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):791-802. PubMed ID: 23582919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development.
    Garcia-Carbonero R; Garcia-Figueiras R; Carmona-Bayonas A; Sevilla I; Teule A; Quindos M; Grande E; Capdevila J; Aller J; Arbizu J; Jimenez-Fonseca P;
    Cancer Metastasis Rev; 2015 Dec; 34(4):823-42. PubMed ID: 26433592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.